Skip to main navigation
Utility Navigation
Careers
Search
Open Menu
Primary Navigation
Close Menu
Pipeline
Our Pipeline
Our Pipeline
Our Pipeline
Imipridones
Oncology
ONC201
for gliomas
ONC206
for central nervous system tumors
ONC212
IND-enabling studies
Publications
Presentations
SNO Conference
Company
Who We Are
Collaborations
Senior Management Team
Board of Directors
Careers
Patients
Expanded Access
Clinical Trials
Products
TEMBEXA®
Investors
Overview
Press Releases
Presentations
Governance
Financials & Filings
Stock Information
Investors FAQ
Request Information
Contact
Event Details
Chimerix Q3 2022 Earnings Conference Call
Nov 3, 2022 at
8:30 AM EDT
Listen to Webcast
Print
Email Alerts
RSS Feeds
Search
Share
scroll back to top of page
